Nordic Adjuvant IFN Melanoma Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1996
The aim of this study is to evaluate the effect of giving adjuvant treatment with intermediate doses of interferon-alpha2b to patients operated for high risk melanoma. Patients are randomly assigned to either observation only or interferon treatment for 2 different durations. The outcome with respect to overall survival, relapse-free survival, side effects and quality of life is analysed.
Epistemonikos ID: a7a172732a70e9126266cfd5f0f5c8358400b667
First added on: Dec 10, 2021